Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: ion channel modulators - Hydra Biosciences

Next Previous
Search
Drug Profile

Research programme: ion channel modulators - Hydra Biosciences

Alternative Names: HC-045314; TRPBH 1; TRPBH 2; TRPBH 3; TRPHB1; TRPHB2

Latest Information Update: 21 Dec 2018

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Hydra Biosciences
  • Class Small molecules
  • Mechanism of Action CATSPER ion channel modulators; Ion channel modulators; TRPV cation channel antagonists; TRPV cation channel modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Hypertension; Inflammation; Kidney disorders; Lung disorders; Osteoporosis; Overactive bladder

Most Recent Events

  • 14 Dec 2018 Eli Lilly and Company acquires TRPA1 antagonists programme from Hydra Biosciences
  • 16 Jul 2018 Hydra Bioscience enters asset transfer agreement for CatSper ion channel target portfolio with Dare Bioscience
  • 16 Jul 2016 No recent reports of development identified for preclinical development in Hypertension in USA

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top